This is a Firm Fixed Price contract awarded by the Food and Drug Administration (FDA), a civilian agency within the U.S. Department of Health and Human Services (HHS), to Sartorius Corporation, a foreign-owned, for-profit manufacturer of laboratory equipment and solutions. The $15,656.00 contract is for preventive maintenance and repair services on a Sartorius Incucyte S3 live-cell analysis system. The contract has a period of performance through September 27, 2025 and was awarded on September 12, 2024 without a set-aside designation. Sartorius Corporation is a key supplier of specialized biomedical instruments, consumables, software, and associated services to various government agencies, particularly within HHS, to support critical research in areas such as infectious diseases, cancer, and drug development. The company has previously received awards from both civilian and defense agencies to provide a range of laboratory equipment and technical services.
Generated 9/14/24, 9:29 AM